Seelos Therapeutics Total Current Liabilities

Seelos Therapeutics (SEEL) currently reports a total current liabilities of $31M as of June 2024. That compares with $56M in the prior-year period — down 45.6% year over year. Use the charts on this page to explore Seelos Therapeutics's total current liabilities history and peer comparisons.

Seelos Therapeutics's total current liabilities decreased from $56M to $31M — a 45.6% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Seelos Therapeutics reported $31M in total current liabilities as of June 2024. That compares with $56M in the prior-year period — down 45.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $31M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Seelos Therapeutics, and consider following SEEL for alerts when major investors trade the stock.

Seelos Therapeutics is classified in the Healthcare sector. On total current liabilities, it currently shows $31M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SEEL with unrelated industries.